enVVeno Medical Corporation (NVNO) Free cash flow 2017–2025
enVVeno Medical Corporation (NVNO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$15.6MFY2025 · since FY2017: -$4.2M → -$15.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.6M | +7.7% |
| FY2024 | -$16.9M | +10.7% |
| FY2023 | -$18.9M | -20.1% |
| FY2022 | -$15.7M | -28.8% |
| FY2021 | -$12.2M | -55.5% |
| FY2020 | -$7.9M | -25.5% |
| FY2019 | -$6.3M | +1.7% |
| FY2018 | -$6.4M | -51.2% |
| FY2017 | -$4.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice